Live Terminal | Security Analysis of CEL.L
TERMINAL beta
Version: 0.1
Timestamp: 1709190928.056659
Options
0Q3.F
53.76%
006220.KS
49.51%
B7J.DE
48.43%
000540.KS
48.07%
BBAI-WT
47.26%
HANA.L
-44.06%
PHLL.L
-50.14%
RAL.PA
-52.20%
GOLL4.SA
-52.40%
HGEN.L
-54.91%
AAPL $180.88 -0.96%
AMD $176.37 -0.92%
AMZN $173.96 0.24%
BRK-B $413.02 1.01%
GOOG $137.26 -2.03%
IBM $184.92 0.03%
INTC $42.16 -1.35%
JNJ $161.21 0.14%
JPM $184.74 0.70%
META $487.18 0.03%
MSFT $407.70 0.05%
O $52.16 -0.28%
TSLA $203.55 1.91%
WMT $59.72 0.21%
QQQ $435.27 -0.5325%
TLT $93.52 0.6349%
VUSA.DE $88.94 0.3317%
VUAA.DE $88.27 0.2863%
FJPR.L $5.63 -0.5650%
VWRP.L $97.51 -0.0102%
VWRL.L $98.20 0.0255%
EMGU.L $3.55 -1.1847%
RDVY $52.62 -0.1518%
FLOT $51.04 0.0294%
SCHZ $45.68 0.2414%
IBB $139.42 -1.0434%
C020.DE $21.34 0.0000%
DFAX $24.53 -0.6480%
LYP6.DE $224.95 -0.3985%
MEUD.PA $225.01 -0.2880%
IQQW.DE $65.41 0.0643%
IDWR.L $70.89 -0.0775%
EXS1.DE $147.20 0.2452%
XESC.L $6900.00 0.0290%
DFAU $35.18 -0.2269%
ACWV $103.29 -0.3377%
VHYD.L $63.68 -0.2897%
VGWD.DE $58.77 -0.1699%
FXKZ.ME $303.00 0.0000%

Latest articles

No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.

Sentiment statistics ?
CEL.L
μ null
null
null

Financial Histories

Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.

Overview
CEL.L
Latest Performance
CEL.L$107.50
$0.00 • 0.00%
CEL.L
Price 107.50
Change Pct 0.00
Change Abs 0.00
Market Cap 69.0 million
Eps -0.13
Pe Ratio -8.27
Outstanding Shares 64.2 million
Volume 3029
Avg Volume 25503
Industry Drug Manufacturers—Specialty & Generic
Sector Name Health Care
Country Short Name GB
Announcement Earnings 2023-09-28 00:00:00+00:00
All metrics in USD or %.
Dividends

There is no dividend data to display. Refer our Dividend calendar for other accurate data.

Risk Profiles

Please sign up and become a member to view all risk profiles.

Competitors/Peer Groups
CEL.L
Same Country:
Same Decade:
Intraday: 0.00%
Focus

The 'Focus' Area is meant to be an One-Pager about all Important Insights, Risks and Opportunities to solely analyze a single corporate.

Company descriptions
CEL.L

Celadon Pharmaceuticals Plc, a pharmaceutical company, engages in the research, manufacture, and supply of cannabinoids for use in approved medicines. The company focuses on growing indoor hydroponic THC cannabis for use in medicinal products used to treat chronic pain. It also intends to conduct research into cannabinoids for use in chronic pain, as well as other conditions, such as autism and multiple sclerosis. The company was founded in 2018 and is headquartered in London, the United Kingdom.